Syncro Medical Innovations
Syncro Medical Innovations is a privately held medical device company founded in 1998 that develops the Gabriel Feeding Tube with Balloon, an enteral feeding device with distal balloon peristalsis migration and CO2-based misplacement detection, sold directly to U.S. hospitals and critical care facilities.
- Company typePrivate
- Founded1998
- HeadquartersMacon, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Syncro Medical Innovations does
Syncro Medical Innovations, Inc. is a privately held medical device company founded in 1998 in Macon, Georgia by Dr. Sabry Gabriel. The company develops and commercializes the Gabriel® Feeding Tube with Balloon (GFTB), an enteral feeding device designed to reduce complications associated with nasogastric tube placement, particularly tracheal misplacement and pneumothorax. Its core technology centers on a distal-end balloon that uses the body's natural peristalsis to migrate the tube post-pylorically, combined with a wire-reinforced wall that resists kinking occlusion and an integrated CO2 sampling line for real-time detection of tracheal misplacement. The current fifth-generation product is ENFit-compliant per ISO 80963-3 and includes a convenience kit for bedside placement.
The company's product line consists of the GFTB 4 Series (Y-connector, 10 and 12 French sizes), the GFTB 5 Series (ENFit connector, 12 French), and the Gabriel 3-Way EnFit Valve accessory (FDA 510(k)-cleared under K201741). Technology development was funded by an NIH-NIDDK grant (Grant #1 R44 DK60268) for foundational research and a Department of Defense Award (W81XWH-09-2-0097) for critical care catheter development. A published clinical study reported no pneumothorax events and 70% post-pyloric migration within 12-24 hours.
Syncro operates a direct-to-facility hardware sales model, with orders placed by phone (888-980-9159) or email to a single named contact. Products are reimbursed under CPT code 43761. The company has approximately 1-10 employees, operates exclusively in the United States, and has raised approximately $4.75 million across funding rounds from 2006 through 2012, with Norwich Ventures identified as a lead investor in the 2006 round. The company has no disclosed M&A activity, no institutional ownership beyond the founder, and no international expansion.
Syncro Medical Innovations firmographics
Firmographics- Name
- Syncro Medical Innovations
- Legal name
- Syncro Medical Innovations, Inc.
- Website
- https://syncromedical.com
- Company type
- Private
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Syncro Medical Innovations is a privately held medical device company founded in 1998 that develops the Gabriel Feeding Tube with Balloon, an enteral feeding device with distal balloon peristalsis migration and CO2-based misplacement detection, sold directly to U.S. hospitals and critical care facilities.
- Ownership category
- akta.pro rank
Syncro Medical Innovations industry classification
Industry- Product category
- Enteral Feeding Devices
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Infusion Sets, Catheters & Pump Consumables (HLAHAIAH)
Keywords
Where Syncro Medical Innovations is headquartered
LocationHeadquarters
- HQ city
- Macon
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Syncro Medical Innovations business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales
Revenue model
- Medical Device Sales: Direct sales of Gabriel Feeding Tube with Balloon products including 4 Series (Y-Connector) and 5 Series (ENFit) models, along with Gabriel 3-Way ENFit Valve accessory. Products sold as complete kits with convenience accessories.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Syncro Medical Innovations product offering
Product offeringCore offering
Syncro Medical Innovations manufactures and sells the Gabriel Feeding Tube with Balloon (GFTB), an enteral feeding device that uses a distal-end balloon and the body's natural peristalsis to migrate the tube to a post-pyloric position. The product line includes the GFTB 4 Series (Y-connector) and 5 Series (ENFit connector), as well as the FDA-cleared Gabriel 3-Way EnFit Valve accessory. Devices are packaged as complete convenience kits and sold directly to hospitals and critical care facilities.
Product overview
Syncro Medical Innovations offers the Gabriel Feeding Tube with Balloon system, an innovative enteral feeding device. The product line includes the GFTB 4 Series (with Y-connector) and GFTB 5 Series (with ENFit connector) as the primary feeding tubes, plus the Gabriel 3-Way EnFit Valve as an accessory. All Gabriel feeding tubes feature a distal balloon that facilitates post-pyloric migration via the body's natural peristalsis and includes CO2 sampling capabilities for safety detection.
Differentiator
Problem solved
Functional benefit
Brands
- GFTB 4 Series: Feeding tube available in 12 French (130 cm) and 10 French (100 cm) sizes with Y-connector and funnel shaped catheter tip port.
- GFTB 5 Series
- Gabriel 3-Way EnFit Valve
Products and services
- Gabriel Feeding Tube with Balloon (GFTB) 5 Series 12 French (130 cm) feeding tube with ENFit connector that can receive a feeding line directly or connect to an ENFit Lopez Valve or the Gabriel 3-way ENFit Valve. Includes a CO2 sampling line for safe insertion and early detection of tracheal misplacement, plus a distal-end balloon that enables post-pyloric migration via natural peristalsis. Packaged as a complete convenience kit.
- Gabriel Feeding Tube with Balloon (GFTB) 4 Series Feeding tube available in 12 French (130 cm) and 10 French (100 cm) sizes with Y-connector (funnel shaped, catheter tip port). Features a CO2 sampling line for safe insertion, an inflated balloon at mid-esophagus for tracheal misplacement detection (verified by stable pulse oximetry), and a balloon at the distal end that enables post-pyloric migration via natural peristalsis. Packaged as a convenience kit.
- Gabriel 3-Way EnFit Valve Three-way closed system valve with three ports providing control of fluid flow for nutrition, medication, and water between devices with ENFit connectors and catheter-tip syringes. FDA approved connector (K201741). Indicated for pediatric, adult, and elderly patients, for use up to 7 days.
Quantifiable outcome
- No undetected lung/tracheal misplacement and no pneumothorax occurred in published clinical study
- +2 more outcomes
Companies that use Syncro Medical Innovations
Customer profileSegments1 record
Ideal customer profiles1 record
Syncro Medical Innovations technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Syncro Medical Innovations partnerships and signals
Strategic signalScale indicators3 records
Recent moves6 records
Expansion highlights3 records
Syncro Medical Innovations competitors and assessment
Company assessmentRegional players
- Medela: Medela is a Swiss-based medical device company with enteral feeding and nutrition delivery products sold in European and select international markets. It is comparable to Syncro as a specialty enteral device player, though its primary geographic focus differs from Syncro's US-centric footprint.
Broad incumbents
- Cook Medical: Cook Medical manufactures a broad range of catheter-based medical devices including enteral feeding products. Its hospital sales force and specialty catheter expertise place it as a broad incumbent peer in the enteral feeding device category.
- Fresenius Kabi: Fresenius Kabi offers enteral nutrition pumps, feeding sets, and consumables used in hospitals. As a leading clinical nutrition and infusion therapy provider, it competes for enteral feeding device contracts alongside its nutrition product portfolio.
- Cardinal Health: Cardinal Health is a major distributor and manufacturer of enteral feeding products, including Kangaroo enteral feeding pumps and consumables. It competes indirectly with Syncro through its broad hospital supply contracts and enteral device portfolio.
- Baxter International: Baxter offers clinical nutrition products and enteral feeding pumps, particularly through its Sigma Spectrum and related infusion/nutrition platforms. It is a broad incumbent competitor serving the same hospital enteral feeding market as Syncro.
- Becton, Dickinson and Company (BD): BD manufactures and distributes a wide range of medical devices including enteral feeding syringes, tubes, and accessories. Its scale, global distribution, and hospital relationships make it a broad incumbent competitor in the enteral feeding device category.
Emerging players
- NeoMed: NeoMed is a specialty enteral device company focused on neonatal and pediatric feeding devices including ENFit-compatible syringes and feeding tubes. As a smaller specialized player with ENFit focus, it shares Syncro's ENFit compliance positioning and specialty feeding tube niche.
Direct peers
- Vygon: Vygon is a French medical device company specializing in single-use enteral, parenteral, and vascular access devices. It competes in enteral feeding tubes and neonatal/adult feeding catheters, sharing a similar specialty catheter focus with Syncro's GFTB.
- Moog Medical Devices Group: Moog Medical (formerly Moog Inc. Medical Devices) manufactures enteral feeding pumps and administration sets used in hospitals and home care. Its enteral feeding product line directly overlaps with Syncro's target market of clinical enteral nutrition delivery.
- Avanos Medical: Avanos Medical (formerly Kimberly-Clark Health Care and CORPAK) is a direct competitor in enteral feeding tubes and related devices. Its Cortrak and related feeding tube systems compete head-to-head with the Gabriel Feeding Tube with Balloon for hospital enteral access contracts.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks6 records
Key highlights6 records
Customer concentration
Syncro Medical Innovations social profiles
Digital presenceSyncro Medical Innovations compliance and trust
Trust signalCompliance1 record
Syncro Medical Innovations financial estimates
Financial estimateRevenue estimate
Valuation estimate
Syncro Medical Innovations leadership team
Management profileNumber of profiles
Profiles1 record
Syncro Medical Innovations funding detail
Funding detailFunding overview
Funding rounds6 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Syncro Medical Innovations M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Syncro Medical Innovations
What does Syncro Medical Innovations do?
Syncro Medical Innovations manufactures and sells the Gabriel Feeding Tube with Balloon (GFTB), an enteral feeding device that uses a distal-end balloon and the body's natural peristalsis to migrate the tube to a post-pyloric position. The product line includes the GFTB 4 Series (Y-connector) and 5 Series (ENFit connector), as well as the FDA-cleared Gabriel 3-Way EnFit Valve accessory. Devices are packaged as complete convenience kits and sold directly to hospitals and critical care facilities.
Is Syncro Medical Innovations a public or private company?
Syncro Medical Innovations is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Syncro Medical Innovations founded?
Syncro Medical Innovations was founded in 1998. It employs 1 to 10 people.
Where is Syncro Medical Innovations based?
Syncro Medical Innovations is headquartered in Macon, United States, in the North America region.
How does Syncro Medical Innovations make money?
One revenue line is on record: medical Device Sales.
Who are Syncro Medical Innovations's main competitors?
Medela is listed as a regional player. Broad incumbents are Cook Medical, Fresenius Kabi, Cardinal Health, Baxter International and Becton, Dickinson and Company (BD). NeoMed is listed as an emerging player. Direct peers are Vygon, Moog Medical Devices Group and Avanos Medical.
Does Syncro Medical Innovations have an API?
No public API is recorded for Syncro Medical Innovations.
What industry is Syncro Medical Innovations in?
Syncro Medical Innovations's product category is Enteral Feeding Devices. Its primary akta.pro industry code is HLAHAIAH, Infusion Sets, Catheters & Pump Consumables. Its NAICS code is 339113 and its SIC code is 3841.